>Title;Machine learning in cardiovascular medicine: are we there yet?
>Date;19/12/2017
>Journal;Heart
>Conflict;Competing interests: PPS is a consultant for TeleHealthRobotics, HeartSciences and Hitachi-Aloka. JTD has received consulting fees or honoraria from Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca and Hoffman-La Roche. JTD is a scientific advisor to LAM Therapeutics and holds equity in NuMedii, Ayasdi and Ontomics. KS has received consulting fees or honoraria from Philips Healthcare, Google, LEK Consulting and Parthenon-EY. All other authors declare no competing interests.
